Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055492
Filed
Sep 10, 2021
Trade date
Jul 1-30, 2021
Filing delay
71 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.03K. It was filed 71 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2021Common StockPPurchaseAcquired+15$2.91+$43.6512,743Direct
Jul 2, 2021Common StockPPurchaseAcquired+15$2.94+$44.112,758Direct
Jul 6, 2021Common StockPPurchaseAcquired+15$3.14+$47.112,773Direct
Jul 7, 2021Common StockPPurchaseAcquired+15$3.21+$48.1512,788Direct
Jul 8, 2021Common StockPPurchaseAcquired+15$3.18+$47.712,803Direct
Jul 9, 2021Common StockPPurchaseAcquired+15$3.13+$46.9512,818Direct
Jul 12, 2021Common StockPPurchaseAcquired+15$3.33+$49.9512,833Direct
Jul 13, 2021Common StockPPurchaseAcquired+15$3.48+$52.212,848Direct
Jul 14, 2021Common StockPPurchaseAcquired+15$3.33+$49.9512,863Direct
Jul 15, 2021Common StockPPurchaseAcquired+15$3.27+$49.0512,878Direct
Jul 16, 2021Common StockPPurchaseAcquired+15$3.28+$49.212,893Direct
Jul 19, 2021Common StockPPurchaseAcquired+15$3.23+$48.4512,908Direct
Jul 20, 2021Common StockPPurchaseAcquired+15$3.24+$48.612,923Direct
Jul 21, 2021Common StockPPurchaseAcquired+15$3.26+$48.912,938Direct
Jul 22, 2021Common StockPPurchaseAcquired+15$3.36+$50.412,953Direct
Jul 23, 2021Common StockPPurchaseAcquired+15$3.35+$50.2512,968Direct
Jul 26, 2021Common StockPPurchaseAcquired+15$3.41+$51.1512,983Direct
Jul 27, 2021Common StockPPurchaseAcquired+15$3.39+$50.8512,998Direct
Jul 28, 2021Common StockPPurchaseAcquired+15$3.42+$51.313,013Direct
Jul 29, 2021Common StockPPurchaseAcquired+15$3.42+$51.313,028Direct
Jul 30, 2021Common StockPPurchaseAcquired+15$3.31+$49.6513,043Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)